These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11758681)

  • 21. Possible role of transforming growth factor-β1 and vascular endothelial growth factor in Fabry disease nephropathy.
    Lee MH; Choi EN; Jeon YJ; Jung SC
    Int J Mol Med; 2012 Dec; 30(6):1275-80. PubMed ID: 23007467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The neurological manifestations of Fabry disease. A review].
    Firsov KV; Kotov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9):98-105. PubMed ID: 27735906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal complications of Fabry disease.
    Basic-Jukic N; Kes P; Coric M; Basic-Kes V
    Curr Pharm Des; 2013; 19(33):6046-50. PubMed ID: 23448456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fabry disease: renal involvement limited to podocyte pathology and proteinuria in a septuagenarian cardiac variant. Pathologic and therapeutic implications.
    Meehan SM; Junsanto T; Rydel JJ; Desnick RJ
    Am J Kidney Dis; 2004 Jan; 43(1):164-71. PubMed ID: 14712441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The kidney in Fabry's disease.
    Pisani A; Visciano B; Imbriaco M; Di Nuzzi A; Mancini A; Marchetiello C; Riccio E
    Clin Genet; 2014 Oct; 86(4):301-9. PubMed ID: 24645664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy.
    Shimohata H; Yamashita M; Ohgi K; Maruyama H; Takayasu M; Hirayama K; Kobayashi M
    CEN Case Rep; 2020 Aug; 9(3):237-242. PubMed ID: 32189245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal manifestations in Fabry disease and therapeutic options.
    Torra R
    Kidney Int Suppl; 2008 Dec; (111):S29-32. PubMed ID: 19039306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preservation of renal function in a patient with Fabry nephropathy on enzyme replacement therapy.
    Torra R; Algaba F; Ars E; Santin S; Fernández-Llama P; Ballarin J
    Clin Nephrol; 2008 Jun; 69(6):445-9. PubMed ID: 18538121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fabry disease: molecular genetics of the inherited nephropathy.
    Desnick RJ; Astrin KH; Bishop DF
    Adv Nephrol Necker Hosp; 1989; 18():113-27. PubMed ID: 2564247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fabry Nephropathy.
    Colpart P; Félix S
    Arch Pathol Lab Med; 2017 Aug; 141(8):1127-1131. PubMed ID: 28745569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular manifestations of Fabry disease and the novel therapeutic strategies.
    Seino Y; Takahashi H; Fukumoto H; Utsumi K; Hirai Y
    J Nippon Med Sch; 2005 Oct; 72(5):254-61. PubMed ID: 16247224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substrate-specific gene expression profiles in different kidney cell types are associated with Fabry disease.
    Shin YJ; Jeon YJ; Jung N; Park JW; Park HY; Jung SC
    Mol Med Rep; 2015 Oct; 12(4):5049-57. PubMed ID: 26135632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Renal lesions in patients with Fabry's disease].
    Gubler MC
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S220-5. PubMed ID: 21211668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease.
    Najafian B; Svarstad E; Bostad L; Gubler MC; Tøndel C; Whitley C; Mauer M
    Kidney Int; 2011 Mar; 79(6):663-670. PubMed ID: 21160462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kidney transplantation and enzyme alpha-galactosidase A therapy in patient with Fabry disease: a case report.
    Dziemianko I; Jezior D; Boratyńska M; Patrzałek D; Kuźniar J; Szyber P; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2925-7. PubMed ID: 18022018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic renal failure, dialysis, and renal transplantation in Anderson-Fabry disease.
    Sessa A; Meroni M; Battini G; Righetti M; Mignani R
    Semin Nephrol; 2004 Sep; 24(5):532-6. PubMed ID: 15490423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term Outcomes of Kidney Transplantation in Fabry Disease.
    Ersözlü S; Desnick RJ; Huynh-Do U; Canaan-Kühl S; Barbey F; Genitsch V; Mueller TF; Cheetham M; Flammer AJ; Schaub S; Nowak A
    Transplantation; 2018 Nov; 102(11):1924-1933. PubMed ID: 29688992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AJKD Atlas of Renal Pathology: Fabry nephropathy.
    Najafian B; Fogo AB; Lusco MA; Alpers CE
    Am J Kidney Dis; 2015 Nov; 66(5):e35-6. PubMed ID: 26498420
    [No Abstract]   [Full Text] [Related]  

  • 39. Ultrastructural study of renal involvement in two females with Anderson-Fabry disease.
    Tosoni A; Nebuloni M; Zerbi P; Vago L; Comotti C; Sessa A
    Ultrastruct Pathol; 2005; 29(3-4):203-7. PubMed ID: 16036875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Fabry Nephropathy: A Literature Review.
    Shimohata H; Yamashita M; Yamada K; Hirayama K; Kobayashi M
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.